Development of Class IIa Bacteriocins as Therapeutic Agents
- PMID: 22187559
- PMCID: PMC3236453
- DOI: 10.1155/2012/386410
Development of Class IIa Bacteriocins as Therapeutic Agents
Abstract
Class IIa bacteriocins have been primarily explored as natural food preservatives, but there is much interest in exploring the application of these peptides as therapeutic antimicrobial agents. Bacteriocins of this class possess antimicrobial activity against several important human pathogens. Therefore, the therapeutic development of these bacteriocins will be reviewed. Biological and chemical modifications to both stabilize and increase the potency of bacteriocins are discussed, as well as the optimization of their production and purification. The suitability of bacteriocins as pharmaceuticals is explored through determinations of cytotoxicity, effects on the natural microbiota, and in vivo efficacy in mouse models. Recent results suggest that class IIa bacteriocins show promise as a class of therapeutic agents.
Figures
References
-
- Klaenhammer T. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiology Reviews. 1993;12(1–3):39–86. - PubMed
-
- Nes IF, Diep DB, Håvarstein LS, Brurberg MB, Eijsink V, Holo H. Biosynthesis of bacteriocins in lactic acid bacteria. Antonie van Leeuwenhoek. 1996;70(2–4):113–128. - PubMed
-
- Cotter PD, Hill C, Ross RP. Bacteriocins: developing innate immunity for food. Nature Reviews Microbiology. 2005;3(10):777–788. - PubMed
-
- van Belkum MJ, Martin-Visscher LA, Vederas JC. Structure and genetics of circular bacteriocins. Trends in Microbiology. 2011;19(8):411–418. - PubMed
-
- Cintas LM, Casaus P, Fernandez MF, Hernandez PE. Comparative antimicrobial activity of enterocin L50, pediocin PA-1, nisin A and lactocin S against spoilage and foodborne pathogenic bacteria. Food Microbiology. 1998;15(3):289–298.
LinkOut - more resources
Full Text Sources
Other Literature Sources
